Madison Asset Management LLC Takes $3.49 Million Position in Synopsys, Inc. $SNPS

Madison Asset Management LLC purchased a new position in Synopsys, Inc. (NASDAQ:SNPS) in the first quarter, Holdings Channel.com reports. The firm purchased 8,800 shares of the semiconductor company’s stock, valued at approximately $3,489,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Norges Bank purchased a new stake in Synopsys during the 4th quarter valued at $730,197,000. State Street Corp boosted its stake in shares of Synopsys by 20.6% in the 3rd quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock worth $4,322,273,000 after buying an additional 1,493,912 shares during the last quarter. Farallon Capital Management LLC bought a new stake in shares of Synopsys in the fourth quarter worth $469,344,000. Assenagon Asset Management S.A. grew its holdings in shares of Synopsys by 390.6% in the fourth quarter. Assenagon Asset Management S.A. now owns 1,186,879 shares of the semiconductor company’s stock worth $557,501,000 after acquiring an additional 944,973 shares during the period. Finally, Primecap Management Co. CA increased its position in Synopsys by 743.6% during the fourth quarter. Primecap Management Co. CA now owns 734,800 shares of the semiconductor company’s stock valued at $345,150,000 after acquiring an additional 647,700 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.

Key Stories Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Mizuho said Moonshot AI’s Kimi K3 release reinforces, rather than weakens, the case for agentic AI and could benefit EDA software leaders like Synopsys, prompting a “buy the dip” view after the recent selloff. Buy the dip in EDA stocks as Kimi K3 boosts agentic AI thesis: Mizuho
• Positive Sentiment: Another analysis argued Synopsys should benefit regardless of which companies win the AI race, since AI development across the industry still requires chip-design software and infrastructure. Synopsys Should Benefit No Matter Who Wins The AI Race. Here’s What Explains Its Poor Stock Performance.
• Neutral Sentiment: Technical-trading coverage said SNPS was testing an important price level and had shown signs of stabilization, suggesting traders may be watching for a reversal rather than reacting to a new business catalyst. Stock Of The Day: Will Synopsys Reverse?
• Neutral Sentiment: Broader market headlines also mentioned SNPS in the context of a firmer futures market, which may have helped sentiment somewhat, but did not add company-specific news. Stock Market Today: S&P 500, Dow Jones Futures Gain as Trump Says Iran is ‘Very, Very Badly Damaged’— Eva Live, RTX, Synopsys in Focus

Synopsys Stock Performance

Shares of SNPS opened at $389.07 on Wednesday. Synopsys, Inc. has a 52 week low of $366.00 and a 52 week high of $651.73. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The stock has a market cap of $74.50 billion, a price-to-earnings ratio of 90.06, a PEG ratio of 2.22 and a beta of 1.22. The business has a 50-day simple moving average of $464.07 and a two-hundred day simple moving average of $457.23.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The company’s revenue was up 41.9% on a year-over-year basis. During the same period in the prior year, the business posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, analysts expect that Synopsys, Inc. will post 10.65 EPS for the current year.

Insider Buying and Selling at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. The trade was a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.56% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on SNPS shares. Piper Sandler raised Synopsys from a “neutral” rating to an “overweight” rating and increased their target price for the company from $450.00 to $550.00 in a report on Tuesday, June 23rd. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a research report on Thursday, May 28th. Rosenblatt Securities increased their price objective on shares of Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research note on Tuesday, May 26th. Stifel Nicolaus boosted their target price on shares of Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $580.00 target price on shares of Synopsys in a report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Synopsys has an average rating of “Moderate Buy” and an average target price of $570.06.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.